News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
469,778 Results
Type
Article (40709)
Company Profile (162)
Press Release (428907)
Section
Business (135806)
Career Advice (1824)
Deals (26934)
Drug Delivery (93)
Drug Development (65829)
Employer Resources (129)
FDA (10480)
Job Trends (10623)
News (244430)
Policy (26956)
Tag
Academia (1958)
Alliances (45164)
Alzheimer's disease (1153)
Antibody-drug conjugate (ADC) (100)
Approvals (10445)
Artificial intelligence (149)
Bankruptcy (262)
Best Places to Work (8416)
Biotechnology (134)
Breast cancer (173)
Cancer (1383)
Cardiovascular disease (96)
Career advice (1504)
CAR-T (107)
Cell therapy (311)
Clinical research (52476)
Collaboration (571)
Compensation (267)
COVID-19 (2509)
C-suite (115)
Data (1230)
Diabetes (172)
Diagnostics (3941)
Earnings (45555)
Employer resources (119)
Events (62978)
Executive appointments (383)
FDA (11115)
Funding (445)
Gene therapy (217)
GLP-1 (658)
Government (4130)
Healthcare (12146)
Infectious disease (2612)
Interviews (302)
IPO (11789)
Job creations (2568)
Job search strategy (1321)
Layoffs (326)
Legal (7305)
Lung cancer (195)
Lymphoma (94)
Manufacturing (201)
Medical device (6199)
Medtech (6201)
Mergers & acquisitions (15407)
Metabolic disorders (490)
Neuroscience (1501)
NextGen: Class of 2025 (4298)
Non-profit (2941)
Northern California (1463)
Obesity (287)
Opinion (229)
Patents (112)
People (36348)
Phase I (16458)
Phase II (23058)
Phase III (17716)
Pipeline (573)
Postmarket research (1913)
Preclinical (6852)
Radiopharmaceuticals (223)
Rare diseases (261)
Real estate (3985)
Regulatory (17001)
Research institute (1778)
Resumes & cover letters (282)
Southern California (1256)
Startups (2739)
United States (12444)
Vaccines (647)
Weight loss (224)
Date
Today (138)
Last 7 days (481)
Last 30 days (2017)
Last 365 days (26820)
2025 (2017)
2024 (27088)
2023 (29950)
2022 (38755)
2021 (41791)
2020 (38613)
2019 (31487)
2018 (24092)
2017 (23604)
2016 (22035)
2015 (25215)
2014 (21241)
2013 (18358)
2012 (16773)
2011 (17490)
2010 (16030)
Location
Africa (708)
Arizona (97)
Asia (30632)
Australia (5532)
California (3280)
Canada (1181)
China (313)
Colorado (128)
Connecticut (154)
Europe (71717)
Florida (441)
Georgia (99)
Illinois (286)
Indiana (167)
Maryland (614)
Massachusetts (2551)
Michigan (133)
Minnesota (179)
New Jersey (986)
New York (952)
North Carolina (523)
Northern California (1463)
Ohio (106)
Pennsylvania (715)
South America (947)
Southern California (1256)
Texas (417)
Washington State (369)
469,778 Results for "dualsystems biotech ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Araris Biotech AG Appoints Dr. Ulf Grawunder to Scientific Advisory Board
Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate - technology, announced the appointment of Ulf Grawunder, Ph.D. to its scientific advisory board.
June 13, 2024
·
3 min read
Press Releases
Dark Genome Biotech HERVolution Therapeutics Announces $11.7M Series A to Advance Treatments for Cancer & Diseases of Aging
December 19, 2024
·
5 min read
Press Releases
Araris Biotech AG Announces Research Collaboration and Option to License Agreement with Chugai Pharmaceutical Co. to Develop Next-Generation ADCs Using Araris’ AraLinQ™ technology
January 8, 2025
·
2 min read
Business
aTyr Pharma Announces Research Collaboration with Dualsystems Biotech AG to Identify 10 New Therapeutic Targets
aTyr Pharma, Inc. today announced that it has entered into a research collaboration with Dualsystems Biotech AG, a company specializing in custom proteomics, aimed at accelerating drug discovery and generating new therapeutics based on aTyr’s extensive intellectual property.
October 11, 2022
·
6 min read
Pharm Country
Eternity Biotech Launches Crowdfunding Campaign on Wefunder to Accelerate Anti-Aging Product Development
Eternity Biotech, Inc., a biotechnology company dedicated to finding solutions for longer, healthier lives, announced the launch of a crowdfunding campaign on Wefunder to advance its anti-aging product development.
April 2, 2024
·
2 min read
Venture capitalists
Lilly Partners With a16z on $500M VC Fund for Early-Stage Biotechs
The Biotech Ecosystem Venture Fund will combine the sourcing capabilities of venture capital firm Andreessen Horowitz (a16z) with Eli Lilly’s expertise in R&D—plus half a billion in capital from the Big Pharma.
January 10, 2025
·
1 min read
·
Annalee Armstrong
Araris Biotech AG Presents Data on Novel Antibody-Drug Conjugates at American Association for Cancer Research (AACR) Annual Meeting 2024
Araris Biotech AG announced the company will deliver two poster presentations, including one late-breaking poster, at this year’s American Association for Cancer Research Annual Meeting being held April 5-10, 2024 at the San Diego Convention Center in San Diego, California.
April 5, 2024
·
3 min read
Business
A Conversation with Peter Marks and Tom Whitehead: Insights into GenScript Biotech Forum 2025 (Teaser)
In this short teaser, BioSpace’s Head of Insights Lori Ellis talks to CBER Director Peter Marks and Tom Whitehead, Co-Founder of the Emily Whitehead Foundation about anticipated discussions at the upcoming GenScript Biotech Forum.
January 10, 2025
·
1 min read
·
Lori Ellis
Venture Capitalists
Novo-Backed Oral Medicine Biotech Adds Lilly to Investors in $93M Series A
Orbis emerged from stealth in February 2024 with $28.1 million in seed funding. The Danish biotech, which aims to flip biologics into oral medicines, has now raised another $93 million.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Funding
Navigating a Biotech Exit in a Rebounding Market
With climbing biotech M&A and IPO activity following the post-pandemic slump, experts offer insights on maximizing value and otherwise capitalizing on exit opportunities.
November 6, 2024
·
8 min read
·
Ana Mulero
1 of 46,978
Next